(Q43584228)

24 November 2017

TNFRSF1B in genetic predisposition to clinical neuropathy and effect on HDL cholesterol and glycosylated hemoglobin in type 2 diabetes (English)

1 reference

24 November 2017

1 reference

1 reference

1 reference

glycosylated hemoglobin

23 October 2023

Benjafield AV

1

1 reference

24 November 2017

Glenn CL

2

1 reference

24 November 2017

Wang XL

3

1 reference

24 November 2017

Colagiuri S

4

1 reference

24 November 2017

Morris BJ

5

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

24 November 2017

1 reference

24 November 2017

24

1 reference

24 November 2017

753-757

1 reference

24 November 2017

4

1 reference

The two different receptors for tumor necrosis factor mediate distinct cellular responses

24 November 2017

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.2337/DIACARE.24.4.753

A cellular rescue team

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.2337/DIACARE.24.4.753

Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance.

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.2337/DIACARE.24.4.753

Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.2337/DIACARE.24.4.753

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.2337/DIACARE.24.4.753

Effects of cytokines, butyrate and dexamethasone on serum amyloid A and apolipoprotein A-I synthesis in human HUH-7 hepatoma cells

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.2337/DIACARE.24.4.753

Anti-tumour necrosis factor-alpha treatment interferes with changes in lipid metabolism in a tumour cachexia model

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.2337/DIACARE.24.4.753

Polymorphism of the tumor necrosis factor-alpha receptor 2 gene is associated with obesity, leptin levels, and insulin resistance in young subjects and diet-treated type 2 diabetic patients

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.2337/DIACARE.24.4.753

Increased levels of soluble tumor necrosis factor receptors in atherosclerosis: no clear relationship with levels of tumor necrosis factor.

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.2337/DIACARE.24.4.753

Autoimmune diabetic neuropathy

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.2337/DIACARE.24.4.753

Tumor necrosis factor alpha: a key component of the obesity-diabetes link

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.2337/DIACARE.24.4.753

High-density lipoproteins protect endothelial cells from tumor necrosis factor-alpha-induced apoptosis

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.2337/DIACARE.24.4.753

The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.2337/DIACARE.24.4.753

Identification of TNFRSF1B as a novel modifier gene in familial combined hyperlipidemia

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.2337/DIACARE.24.4.753

Tumor necrosis factor alpha is a determinant of pathogenesis and disease progression in mycobacterial infection in the central nervous system

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.2337/DIACARE.24.4.753

Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure.

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.2337/DIACARE.24.4.753

Tumor necrosis factor in CHF: a double facet cytokine.

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.2337/DIACARE.24.4.753

Gliclazide inhibits diabetic neuropathy irrespective of blood glucose levels in streptozotocin-induced diabetic rats

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.2337/DIACARE.24.4.753

Tumor necrosis factor stimulates hepatic lipid synthesis and secretion

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.2337/DIACARE.24.4.753

Tumor necrosis factor receptor 2 gene (TNFRSF1B) in genetic basis of coronary artery disease

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.2337/DIACARE.24.4.753

Tumor necrosis factor's cytotoxic activity is signaled by the p55 TNF receptor

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.2337/DIACARE.24.4.753

Physical mapping and genomic structure of the human TNFR2 gene.

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.2337/DIACARE.24.4.753

Linkage and association of tumor necrosis factor receptor 2 locus with hypertension, hypercholesterolemia and plasma shed receptor

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.2337/DIACARE.24.4.753

A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.2337/DIACARE.24.4.753

Tumor necrosis factor system activity is associated with insulin resistance and dyslipidemia in myotonic dystrophy.

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.2337/DIACARE.24.4.753

Prospects for whole-genome linkage disequilibrium mapping of common disease genes

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.2337/DIACARE.24.4.753

Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.2337/DIACARE.24.4.753

The role of TNF-alpha in human adipose tissue: prevention of weight gain at the expense of insulin resistance?

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.2337/DIACARE.24.4.753

Genetic epidemiology of single-nucleotide polymorphisms.

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.2337/DIACARE.24.4.753

Identifiers

DOI

10.2337/DIACARE.24.4.753

1 reference

24 November 2017

1 reference